title: Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans.
abstract: The recently identified adipocytokine adiponectin has been shown to improve insulin action and decrease triglyceride content in skeletal muscle (by stimulating lipid oxidation) in mice. In the present study, we tested the hypothesis that high serum concentrations of adiponectin are associated with lower intramyocellular (IMCL) fat content by promoting lipid oxidation in humans. IMCL-content in predominantly non-oxidative tibialis anterior muscle and oxidative soleus was determined by proton magnetic resonance spectroscopy in a cross- sectional study involving 63 healthy volunteers. In a second set of experiments, changes in IMCL in both muscles were measured after a three days dietary lipid challenge (n = 18) and after intravenous lipid challenge (n = 12) with suppressed lipid oxidation under hyperinsulinemia. Adiponectin serum concentrations were found to be negatively correlated with IMCL in the oxidative soleus muscle (IMCL [sol]) (r = - 0.46, p < 0.001) independent of measures of obesity, but not with IMCL in the non-oxidative tibialis anterior muscle (IMCL [tib]) (p = 0.40). Adiponectin serum concentrations were negatively correlated with the observed increase in IMCL load after dietary lipid challenge in the tibialis (r = 0.53, p = 0.03) but not in the soleus muscle. During suppression of lipid oxidation by hyperinsulinemia, no effect of adiponectin on IMCL was observed in either soleus or tibialis muscle. Overall, the presented findings are consistent with the hypothesis that adiponectin promotes lipid oxidation in humans resulting in lower intracellular lipid content in human muscle. These results are consistent with animal data, where adiponectin could be shown to enhance lipid oxidation and reduce muscle triglycerides.
authors.affiliation: Department of Endocrinology and Metabolism, Eberhard-Karls-University, Tübingen, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Thamer
authors.forename: J
authors.initials: J
authors.lastname: Machann
authors.forename: O
authors.initials: O
authors.lastname: Tschritter
authors.forename: M
authors.initials: M
authors.lastname: Haap
authors.forename: B
authors.initials: B
authors.lastname: Wietek
authors.forename: D
authors.initials: D
authors.lastname: Dahl
authors.forename: O
authors.initials: O
authors.lastname: Bachmann
authors.forename: A
authors.initials: A
authors.lastname: Fritsche
authors.forename: S
authors.initials: S
authors.lastname: Jacob
authors.forename: M
authors.initials: M
authors.lastname: Stumvoll
authors.forename: F
authors.initials: F
authors.lastname: Schick
authors.forename: H-U
authors.initials: HU
authors.lastname: Häring
mesh_terms: D052242:Adiponectin; D000328:Adult; D003430:Cross-Sectional Studies; D004041:Dietary Fats / Q000378:metabolism; D004734:Energy Metabolism / Q000502:physiology; D005260:Female; D006801:Humans; D007328:Insulin / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins; D008053:Lipid Mobilization / Q000502:physiology*; D015227:Lipid Peroxidation / Q000502:physiology; D008297:Male; D032342:Muscle Cells / Q000378:metabolism*; D018657:Muscle Fibers, Slow-Twitch / Q000378:metabolism; D018482:Muscle, Skeletal / Q000166:cytology / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism*; D012016:Reference Values; D014280:Triglycerides / Q000378:metabolism*
chemical_list: D052242:Adiponectin; D004041:Dietary Fats; D007328:Insulin; D036341:Intercellular Signaling Peptides and Proteins; D011506:Proteins; D014280:Triglycerides